BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 11, 2018 | $1,060,000 | Replaced |
| 2nd Quarter - Amendment | Sep 14, 2020 | $1,060,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
Anti-Counterfeiting; S.469 - The Affordable and Safe Drug Importation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
| LEAH D SVOBODA | — |
| MARY BRIDGET WALSH | — |
Accounting ACC
Importation - Affordable and Safe Prescription Drug Importation Act- Sanders
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
| LEAH D SVOBODA | — |
| MARY BRIDGET WALSH | — |
Health Issues HCR
Cost Sharing (Preserving Access to Medicines); S. Amendment 178; to S. Con. Res. 3 and HR/245 & S.469 House & Senate bills titled the Affordable Safe and Prescription Drug Importation Act. Diabetes and Heart Health Awareness and Chronic Pulmonary Disease Awareness
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
| LEAH D SVOBODA | — |
Medicare/Medicaid MMM
Average Sales Price; Reimbursement; CMS Rule coding for Biosimilars; Biosimilars and the Part D Coverage Gap Discount; Biosimilars Pass-Through Status in Part B
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
| LEAH D SVOBODA | — |
| MARY BRIDGET WALSH | — |
Budget/Appropriations BUD
House & Senate Budget Bills; Rebates for Dual Eligible, Low Income Subsidy Populations and Drug Pricing in the following: S. Con. Res. 3 - 2017 Budget President's 2018 Budget Blue Print Bipartisan Budget Act of 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
| LEAH D SVOBODA | — |
| MARY BRIDGET WALSH | — |
Animals ANI
Animal Health - The Animal Drug and Animal Generic Drug User Fee Amendments of 2018 Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL DAVIS | — |
| LEAH D SVOBODA | — |
| MARY BRIDGET WALSH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.